China National Medicines Corp Ltd (600511) — Free Cash Flow Generation Index
China National Medicines Corp Ltd (600511) has a Free Cash Flow Generation Index of 0.97x as of June 2025. Free cash flow of CN¥369.51 Million represents 1% of operating cash flow (CN¥382.74 Million). Explore China National Medicines Corp Ltd (600511) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
China National Medicines Corp Ltd Free Cash Flow Generation Index (2002–2024)
Historical FCF Generation Index trend for China National Medicines Corp Ltd across 22 annual periods. For the full cash flow conversion analysis, see 600511 operating cash flow.
Annual Free Cash Flow Generation for China National Medicines Corp Ltd (2002–2024)
Year-by-year Free Cash Flow Generation Index for China National Medicines Corp Ltd. Check total reinvestment intensity of China National Medicines Corp Ltd to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.92x | CN¥1.53 Billion | CN¥1.66 Billion | CN¥130.77 Million | ▼ -2.7% |
| 2023 | 0.95x | CN¥2.58 Billion | CN¥2.73 Billion | CN¥145.12 Million | ▲ +0.1% |
| 2022 | 0.95x | CN¥2.27 Billion | CN¥2.40 Billion | CN¥129.78 Million | ▼ -0.6% |
| 2021 | 0.95x | CN¥1.86 Billion | CN¥1.96 Billion | CN¥95.07 Million | ▲ +0.5% |
| 2020 | 0.95x | CN¥1.23 Billion | CN¥1.30 Billion | CN¥69.05 Million | ▼ -0.5% |
| 2019 | 0.95x | CN¥1.69 Billion | CN¥1.78 Billion | CN¥85.72 Million | ▲ +10.0% |
| 2018 | 0.87x | CN¥849.19 Million | CN¥981.65 Million | CN¥132.46 Million | ▼ -7.2% |
| 2017 | 0.93x | CN¥1.00 Billion | CN¥1.07 Billion | CN¥73.25 Million | ▼ -0.1% |
| 2016 | 0.93x | CN¥551.38 Million | CN¥591.25 Million | CN¥39.88 Million | ▲ +10.4% |
| 2015 | 0.84x | CN¥371.82 Million | CN¥440.29 Million | CN¥68.47 Million | ▲ +161.5% |
| 2014 | 0.32x | CN¥70.72 Million | CN¥218.94 Million | CN¥148.22 Million | ▼ -6.2% |
| 2013 | 0.34x | CN¥63.91 Million | CN¥185.56 Million | CN¥121.66 Million | ▲ +294.7% |
| 2012 | 0.09x | CN¥16.22 Million | CN¥185.87 Million | CN¥169.65 Million | ▼ -90.6% |
| 2010 | 0.92x | CN¥294.12 Million | CN¥318.21 Million | CN¥24.09 Million | ▲ +1.3% |
| 2009 | 0.91x | CN¥232.85 Million | CN¥255.18 Million | CN¥22.33 Million | ▼ -1.4% |
| 2008 | 0.93x | CN¥200.89 Million | CN¥217.10 Million | CN¥16.21 Million | ▲ +3.8% |
| 2007 | 0.89x | CN¥70.86 Million | CN¥79.48 Million | CN¥8.61 Million | ▲ +10.9% |
| 2006 | 0.80x | CN¥97.69 Million | CN¥121.50 Million | CN¥23.81 Million | ▲ +45.5% |
| 2005 | 0.55x | CN¥50.96 Million | CN¥92.20 Million | CN¥41.24 Million | ▲ +171.7% |
| 2004 | -0.77x | CN¥-37.90 Million | CN¥49.18 Million | CN¥87.08 Million | ▲ +99.6% |
| 2003 | -171.79x | CN¥-90.39 Million | CN¥526.15K | CN¥90.92 Million | ▼ -260133.2% |
| 2002 | 0.07x | CN¥1.00 Million | CN¥15.19 Million | CN¥14.19 Million | — |